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In lymphocytes, the three NFAT factors NFATc1 (also designated as NFAT2), NFATc2
(NFAT1), and NFATc3 (NFAT4 or NFATx) are expressed and are the targets of immune
receptor signals, which lead to a rapid rise of intracellular Ca++, the activation of phos-
phatase calcineurin, and to the activation of cytosolic NFATc proteins. In addition to rapid
activation of NFAT factors, immune receptor signals lead to accumulation of the short
NFATc1/αA isoform in lymphocytes which controls their proliferation and survival. In this
mini-review, we summarize our current knowledge on the structure and transcription of
the Nfatc1 gene in lymphocytes, which is controlled by two promoters, two poly A addition
sites and a remote downstream enhancer. The Nfatc1 gene resembles numerous primary
response genes (PRGs) induced by LPS in macrophages. Similar to the PRG promoters, the
Nfatc1 promoter region is organized in CpG islands, forms DNase I hypersensitive sites,
and is marked by histone tail modifications before induction. By studying gene induction
in lymphocytes in detail, it will be important to elucidate whether the properties of the
Nfatc1 induction are not only typical for the Nfatc1 gene but also for other transcription
factor genes expressed in lymphocytes.
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INTRODUCTION
In peripheral B lymphocytes, the NFATc factors NFATc1, c2, and
c3 are the final targets of B cell receptor (BCR)-mediated activa-
tion, and inhibiting their induction by the immunosuppressant
Cyclosporin A (CsA) abrogates the antigen-induced proliferation
of B cells (1). In freshly isolated (naive) splenic B cells according
to the number of RNA reads in RNA Seq assays, 10-fold more
transcripts were detected for the Nfatc1 and Nfatc3 genes than
for the Nfatc2 gene. BCR signals increase the transcription of the
Nfatc1 gene, but not of the Nfatc2 and Nfatc3 genes (Muham-
mad et al., submitted). Although all three NFATc transcription
factors (TFs) bind to similar DNA motifs and transactivate the
promoters of numerous genes in transfection studies, inactivating
the individual Nfatc genes in mice resulted in quite diverging phe-
notypes. Whereas inactivation of the Nfatc1 gene led to an early
death of mice embryos (2, 3), Nfatc2−/− mice were born at nor-
mal Mendelian ratio but developed with age, a hyper-proliferative
syndrome and elevated immune responses (4–6). These features
of the Nfatc2−/− mice were found to be accelerated in mice defi-
cient in both NFATc2 and NFATc3 (7). Ablation of NFATc1 in
B cells led to a marked reduction in BCR-mediated proliferation
and Ca++ flux, increase in activation induced cell death (AICD),
and defects in antibody production upon immunization, whereas
opposite effects were observed for Nfatc2−/− B cells (1, 8).
These functional differences between NFATc1 and NFATc2
might be due to the synthesis of NFATc1/αA, a short isoform of
NFATc1, which lacks the C-terminal peptide of approximately 250
amino acids residues typical for most of the other NFATc proteins.
NFATc1/αA is the most prominent NFAT protein in effector B cells
and is able to rescue B cells from early cell death (1).
STRUCTURE OF THE Nfatc1 GENE
The genes encoding NFATc1 in mouse and man consist of 11
exons and span approximately 110 and 134 kb DNA, respectively.
Due to the existence of two promoters, two poly A sites and alter-
nate splicing events, six NFATc1 RNAs, and proteins are generated
in peripheral lymphocytes (9–11) (Figure 1A). The two Nfatc1
promoters, P1 and P2, show the typical features of eukaryotic
promoters. They are highly conserved between mouse and man
over 800 bp (P1) or 100 bp (P2) DNA and form DNase I hyper-
sensitive chromatin sites. Both promoters are organized in CpG
islands. While in peripheral blood lymphocytes, in Jurkat T cells,
and in other lymphoid cell lines in which NFATc1 is expressed the
DNA of promoter islands is de-methylated, inactivation of human
NFATC1 gene in several Hodgkin’s lymphoma cells lines is corre-
lated with the methylation of all CpG dinucleotides within the P1
promoter (12).
The inducible P1 promoter of 800 bp can be divided into
two DNA “homology blocks” (10) of approximately 250 bp DNA,
which harbor DNA binding motifs for Sp1 at their termini. Sp1
binding is known to protect CpG islands from DNA methyla-
tion (19, 20), and the relatively weak binding of Sp1 to these
P1 sites in Hodgkin’s lymphoma cells in which the promoter is
suppressed led us to speculate that they could function as “road
blocks” to prevent the methylation of P1 DNA in effector lympho-
cytes (12) [but see also Ref. (21) and below for the function of
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FIGURE 1 | Molecular organization and epigenetic marks of the Nfatc1
gene. (A) Exon–intron structure of the murine Nfatc1 gene. The two
promoters P1 (red) and P2 (blue) and the two poly A addition sites pA1 and
pA2 (both in green) are indicated. In intron 10, an enhancer for the Nfatc1
induction in lymphocytes is located, and at the 3′ end of intron 1, an
enhancer was described for controlling Nfatc1 transcription in endocardial
cells of the developing heart (13). (B) Occurrence of DNase I hypersensitive
sites in the human NFATC1 gene in CD34+ hematopoietic progenitor cells
and CD3+ T cells (see http://nihroadmap.nih.gov/epigenomics (14). Note the
existence of DNase I hypersensitivity over the promoter region and the
intron 10 in which we identified an enhancer for the induction of Nfatc1
gene (Patra et al., in preparation; see below). (C) Epigenetic H3K4me3
marks – as indicator for regulatory elements, which are either poised for or
active in transcription (15) – at the promoter region and intron 10 sites in Th1
and Th2 cells (16). Note the appearance of H3K4me3 mark around the P1
and P2 promoters in all types of T cells, whereas the occurrence of
H3K4me3 mark in intron 10 is restricted to Th1 and Th2 in which we
observed a strong Nfatc1 induction upon cellular activation (17).
(D) Accumulation of RNA polymerase II (pol II) and of epigenetic marks on
the Nfatc1 gene in DP thymocytes (18). Note the appearance of pol II at
promoter P2 and of enhancer mark H3K4me1 in the promoter region and
intron 10.
Sp1 in the control of primary response promoters]. The TF bind-
ing motifs within each block of homology represent composite
sites for the inducible binding of Creb/Fos/ATF and NF-κB/NFAT
factors. When used as probes in electrophoretic band shift assays
(EMSAs), the NF-κB/NFAT sites form predominantly NF-κB com-
plexes with proteins from activated T and B cells. However, under
conditions of high nuclear NFAT levels these sites can also be
bound by NFAT. Together with the two NFAT sites within the dis-
tal block of homology, which are arranged in tandem, they enable
strong binding of NFAT factors to the P1 promoter (9). This con-
tributes to the NFATc1-mediated auto-regulation of P1-directed
Nfatc1 transcription, which keeps high levels of NFATc1 for days
under persistent immune receptor stimulation (11).
In spite of the tight assembly of TF binding sites within the P1
promoter, when transfected into EL-4 thymoma cells, P1-directed
luciferase reporter constructs showed a poor induction, which dif-
fers markedly from the induction of endogenous Nfatc1 gene (9).
Instead of being induced as the endogenous Nfatc1 gene by the
phorbol ester TPA and the Ca++-ionophore ionomycin (which
mimic immune receptor signals), inducers of protein kinase A,
such as forskolin, led in combination with ionomycin to the
strongest induction of P1 in EL-4 thymoma cells (9).
These functional studies on the induction of Nfatc1 P1 pro-
moter led us to conclude that not all sequence elements controlling
the induction of the Nfatc1 gene in lymphocytes are part of its
promoter region. Whereas fusion of more upstream DNA to the
highly conserved P1 region of approximately 800 bp did not result
in any increase in promoter induction, fusion of a 1-kb DNA frag-
ment from the central region of intron 1 of the Nfatc1 gene to
P1 enhanced its overall activity fourfold to fivefold, but did not
affect its induction mode (9). However, when we inserted an ele-
ment from intron 10 of the Nfatc1 gene into a luciferase construct
directed by the P1 (or P2) promoter, we observed both a strong
increase in promoter induction and a mode of induction simi-
lar to the endogenous Nfatc1 gene. These findings suggest that an
enhancer for the optimal induction of Nfatc1 gene is located in
intron 10, which supports Nfatc1 induction in lymphocytes (Patra
et al., in preparation).
In Figures 1B,C, mapping studies of DNase I hypersensitive
sites in human CD34+ lymphoid progenitor cells and CD3+ T
cells and of H3K4me3 mark in various subsets of murine T cells
are presented for the Nfatc1 gene. They show that, in addition to
the promoter region, both DNase I hypersensitive chromatin sites
and H3K4me3 marks were mapped within intron 10 of Nfatc1.
The distal intron 10 site was found to be marked by H3K4me1
and H3K4me3 modifications (see Figures 1C,D), and the enrich-
ment of H3K4me3 was identified as a feature of active enhancers
in T cells (22). And indeed, we determined this site (designated as
E2) as an enhancer element that supports the induction of P1 and
P2 promoters in lymphocytes (Patra et al., in preparation). Inter-
estingly, E2 appears to be less active (or inactive) in Th17 cells,
in thymus-derived regulatory T cells (Treg), and in induced Treg
(iTreg) in which we observed a weak Nfatc1 induction (17).
In resting CD4+ T cells and DP thymocytes in which Nfatc1
is poorly expressed, the (P2) promoter region of the Nfatc1 gene
shows characteristics of a “transcription initiation platform.” In
ChIP-Seq assays using DP thymocytes, the RNA polymerase II
(pol II) was found to be bound at P2 (and not at P1), whereas the
enhancer mark H3K4me1 was detected over the entire promoter
region and several intron 10 sites (Figure 1D) (18). However, when
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ChIP assays were performed for H3K27ac, a mark for active – and
not only poised – enhancers (23), only a peak over the central
intron 10 enhancer segment E2 appeared in double-negative (DN)
thymocytes (Andrau, in preparation) in which the Nfatc1 gene is
expressed more robustly than in DP thymocytes (17).
Nfatc1 EXPRESSION IN PERIPHERAL B CELLS
When splenic B cells are induced by α-IgM for 24 h ex vivo,
the predominant synthesis of short NFATc1 isoform NFATc1/αA
is observed (1, 17). While in Western blots using whole B cell
protein a strong, more than 50-fold induction of NFATc1/αA pro-
tein is detected, in real time PCR assays measuring the levels of
Nfatc1/αA RNA a 5- to 10-fold increase was observed, and in
recent RNA Seq assays, high levels of NFATc1 RNA were found in
non-stimulated primary splenic B cells, which are not reflected
at the protein level. These observations suggest the existence
of both transcriptional and post-transcriptional control mecha-
nisms, which shape the appearance of NFATc1 protein(s) upon B
(and T) cell induction.
To study the expression of Nfatc1 gene at the transcriptional
level in vivo, we generated a BAC transgenic (tg) mouse line, which
expresses an Egfp reporter gene under the control of the entire
Nfatc1 locus (17). Within the BAC construct, the Egfp reporter
replaces exon 3 of the Nfatc1 gene followed by a SV40 poly A addi-
tion signal, which gives rise to short chimeric Nfatc1/Egfp RNAs
and proteins. Therefore, the Nfatc1/Egfp transcripts are generated
under the control of all regulatory elements of the Nfatc1 gene,
including both promoters and the downstream enhancer. How-
ever, the post-transcriptional mechanisms leading to NFATc1/αA
protein differ certainly between “normal” Nfatc1 and Nfatc1/Egfp
transcripts. Thus, in lymphocytes of tg Nfatc1/Egfp mice, the
expression of chimeric Nfatc1/Egfp tg should reflect the tran-
scription of Nfatc1 locus, but not the expression of NFATc1
proteins.
In tg Nfatc1/Egfp mice, the Nfatc1 gene is expressed as early as
in DN thymocytes and in naïve resting T and B cells of periph-
eral lymphoid organs. Although before the induction of pre-T cell
receptor at the transition of DN3 to DN4 thymocytes, NFATc1 α-
isoforms are not generated and, therefore, the P1 promoter is less
active (or inactive), the Nfatc1 gene appears to be transcribed at a
relatively high level in DN thymocytes lacking any immune recep-
tor (Patra et al., in preparation). This appears also to be the case in
naïve and resting T and B lymphocytes. Thus, similar to other TF
genes encoding Fos, Jun, Egr, ATF, and further TF factors, which
harbor CpG islands in their promoters, the Nfatc1 gene seems to
belong to the group of primary response genes (PRGs) that show a
moderate 5- to 10-fold induction upon cellular stimulation. Con-
trary to secondary response genes (SRGs), which are often induced
more than 100-fold, PRGs appear to be organized in an “open”
chromatin, which is poised for transcription or transcribed at a
low level (24, 25).
To a large part, our current view on the regulation of inducible
genes bases on studies about LPS-mediated gene induction in
macrophages (21, 26), see also (27) and (24). Previous approaches
on the knock down of components of SWI/SNF nucleosome
remodeling complexes in macrophages showed that in contrast
to the SWI/SNF-dependent induction of SRGs, the LPS-mediated
induction of PRGs is independent of SWI/SNF (28). Similar to
promoters of many house-keeping genes, which are also organized
in CpG islands, PRG promoters exhibit constitutively active chro-
matin with unstable nucleosomes, which form constitutive DNase
I hypersensitive regions (26). Before induction, they are associ-
ated with the initiating version of pol II phosphorylated at “Ser5”
within their C-terminal domain (CTD), and with Sp1, which helps
to recruit pol II. But contrary to the heat shock genes in Drosophila,
which are also pre-loaded with pol II and transcribed into short
RNAs (29), PRG transcripts in macrophages are elongated to full-
length transcripts, which appear to be instable and un-spliced (21).
LPS stimulation, however, which often leads to binding of NF-κB
to the promoters of PRGs results in the phosphorylation of pol II
at position S2 within its CTD repeats and the generation of stable
RNAs, which are spliced and processed (21, 26).
The architecture of the Nfatc1 promoter region and its induc-
tion is similar, but not in all aspects, to PRG promoters and
their induction in macrophages. In lymphocytes, induction of
the Nfatc1 gene is controlled predominantly by immune recep-
tor signals but not by LPS [or other co-stimulatory signals; see
Ref. (1)]. The Nfatc1 promoter region is organized in CpG islands,
forms DNase I hypersensitive sites, and is bound by Sp1 [and
CREB, which controls activity-dependent PRG regulation in neu-
rons (30)] prior to its induction by NF-κB. However, induction
of the Nfatc1 promoter differs significantly from that of PRG pro-
moters in macrophages. In contrast to PRGs (31) and similar to
the “inducible house-keeping” Nfkbia gene (21), the Nfatc1 gene
is efficiently transcribed in lymphocytes prior to the appearance
of stable, spliced transcripts in response to receptor signals. These
transcripts, however, remain un-translated (Muhammad et al., in
preparation.).
SUMMARY AND IMPLICATIONS
The immune receptor-mediated induction of NFATc1 TFs in
peripheral lymphocytes can be divided in two events: (i) the
rapid nuclear transport and activation of pre-formed cytosolic
NFATc proteins, and (ii) the massive transcriptional and post-
transcriptional induction of NFATc1/αA, a short NFATc1 protein,
which differs in many properties from other NFATc proteins (10).
Although the induction of the Nfatc1 gene leading to NFATc1/αA
in lymphocytes resembles the LPS-mediated induction of PRGs
in macrophages, it appears to differ from the induction of many
PRGs by (i) its high constitutive transcription into spliced tran-
scripts and (ii) its enhancer-mediated control. While the molecular
details of these events remain to be elucidated, it will be impor-
tant to investigate whether the properties of Nfatc1 induction are
specific for the Nfatc1 gene or a property of immune receptor-
mediated induction of many TF genes in lymphocytes. In any
way, the detailed knowledge of molecular mechanisms controlling
the induction of NFATc1 in lymphocytes could pave the way to
interfere with its induction, which controls numerous aspects of
adaptive immunity.
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